BIO-PATH HOLDINGS, INC. financial data

Symbol
BPTH on OTC
Location
Bellaire, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 29% % -72%
Debt-to-equity -143% % 84%
Return On Equity 478% %
Return On Assets -595% % -85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,242,151 shares
Common Stock, Shares, Outstanding 9,242,151 shares 149%
Entity Public Float $5,042,574 USD -63%
Common Stock, Value, Issued $9,000 USD 125%
Weighted Average Number of Shares Outstanding, Basic 8,308,000 shares 415%
Weighted Average Number of Shares Outstanding, Diluted 8,521,000 shares 182%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $8,117,000 USD 4.7%
General and Administrative Expense $2,799,000 USD -40%
Operating Income (Loss) $10,916,000 USD 12%
Nonoperating Income (Expense) $262,000 USD -114%
Net Income (Loss) Attributable to Parent $11,178,000 USD -6.3%
Earnings Per Share, Basic 0.97 USD/shares 53%
Earnings Per Share, Diluted 1.56 USD/shares 84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $0 USD
Other Assets, Current $189,000 USD -90%
Assets, Current $663,000 USD -77%
Property, Plant and Equipment, Net $9,000 USD -81%
Operating Lease, Right-of-Use Asset $27,000 USD 12%
Assets $690,000 USD -77%
Accounts Payable, Current $4,898,000 USD 373%
Accrued Liabilities, Current $2,963,000 USD 28%
Liabilities, Current $8,683,000 USD 157%
Operating Lease, Liability, Noncurrent $3,000 USD -96%
Liabilities $8,694,000 USD 136%
Retained Earnings (Accumulated Deficit) $125,926,000 USD -9.7%
Stockholders' Equity Attributable to Parent $8,004,000 USD -1024%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7,158,000 USD -654%
Liabilities and Equity $690,000 USD -77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,313,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $262,000 USD 51%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 9,242,151 shares 149%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,051,000 USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 USD -100%
Deferred Tax Assets, Valuation Allowance $27,626,000 USD 14%
Deferred Tax Assets, Gross $27,643,000 USD 14%
Operating Lease, Liability $83,000 USD -27%
Depreciation $2,000 USD -91%
Lessee, Operating Lease, Liability, to be Paid $86,000 USD -28%
Property, Plant and Equipment, Gross $1,010,000 USD -9.8%
Operating Lease, Liability, Current $27,000 USD 3.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $86,000 USD -20%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,000 USD -50%
Deferred Tax Assets, Operating Loss Carryforwards $19,263,000 USD 3.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $117,912,000 USD 3.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $17,000 USD -19%
Share-based Payment Arrangement, Expense $27,000 USD -73%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%